AstraZeneca to supply Covid-19 antibody cocktail to Singapore
The US Food and Drug Administration on Wednesday authorised the use infections in individuals with weak immune systems or a history of severe side effects from coronavirus vaccines
The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, US, March 22, 2021. Photo: Reuters
AstraZeneca said on Friday it will supply Singapore with its Covid-19 antibody cocktail, Evusheld, by the end of the year.
Evusheld can act as another layer of protection, alongside vaccines, for people who are at high risk of Covid-19 infection, according to AstraZeneca's statement.
The company did not specify how many courses of the treatment would be supplied to the Southeast Asian city-state.
Keep updated, follow The Business Standard's Google news channel
The US Food and Drug Administration on Wednesday authorised the use infections in individuals with weak immune systems or a history of severe side effects from coronavirus vaccines.
